| Analysis | Metabolite Name | Measured Value | Units | subject type |
|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+ | 1915 | Peak area | Severe disease |
| Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+ | 2412 | Peak area | Severe disease |
| Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+ | 2981 | Peak area | Healthy control |
| Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+ | 3509 | Peak area | Severe disease |
| Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+ | 7589 | Peak area | Mild disease |
| Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+ | Peak area | Healthy control | |
| Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+ | Peak area | Mild disease | |
| Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+ | Peak area | Severe disease |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|